- Home
- FLG vs ALKS Comparison
FLG vs ALKS Comparison
Compare FLG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLG
- ALKS
- Stock Information
- Founded
- FLG 1859
- ALKS 1987
- Country
- FLG United States
- ALKS Ireland
- Employees
- FLG N/A
- ALKS N/A
- Industry
- FLG
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FLG
- ALKS Health Care
- Exchange
- FLG NYSE
- ALKS Nasdaq
- Market Cap
- FLG 4.2B
- ALKS 4.5B
- IPO Year
- FLG 1993
- ALKS 1991
- Fundamental
- Price
- FLG $11.73
- ALKS $27.84
- Analyst Decision
- FLG Buy
- ALKS Buy
- Analyst Count
- FLG 5
- ALKS 12
- Target Price
- FLG $13.00
- ALKS $38.55
- AVG Volume (30 Days)
- FLG 6.6M
- ALKS 1.9M
- Earning Date
- FLG 04-25-2025
- ALKS 05-01-2025
- Dividend Yield
- FLG 0.34%
- ALKS N/A
- EPS Growth
- FLG N/A
- ALKS 3.47
- EPS
- FLG N/A
- ALKS 2.17
- Revenue
- FLG $1,553,000,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- FLG $23.40
- ALKS N/A
- Revenue Next Year
- FLG $21.63
- ALKS $4.09
- P/E Ratio
- FLG N/A
- ALKS $12.83
- Revenue Growth
- FLG N/A
- ALKS N/A
- 52 Week Low
- FLG $7.86
- ALKS $22.90
- 52 Week High
- FLG $13.35
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- FLG N/A
- ALKS 36.32
- Support Level
- FLG N/A
- ALKS $26.70
- Resistance Level
- FLG N/A
- ALKS $27.95
- Average True Range (ATR)
- FLG 0.00
- ALKS 1.25
- MACD
- FLG 0.00
- ALKS 0.06
- Stochastic Oscillator
- FLG 0.00
- ALKS 46.82
About FLG FLAGSTAR FINANCIAL INC
Flagstar Financial Inc operates over 400 branches, including a presence in the Northeast and Midwest and locations in high-growth markets in the Southeast and West Coast. In addition, the Bank has approximately 90 private banking teams located in over 10 cities in the metropolitan New York City region and on the West Coast, which serve the needs of high net-worth individuals and their businesses.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.